Outcome of autologous stem cell transplantation in patients with favorable-risk acute myeloid leukemia in first remission

OBJECTIVE: To evaluate the efficacy of autologous hematopoietic stem cell transplantation (auto-HSCT) in patients with favorable-risk acute myeloid leukemia in first remission. METHOD: Twenty patients who received auto-HSCT at our center between January 2014 and January 2021 were retrospectively rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Juan, Liu, Li, Ma, Runzhi, Pang, Aiming, Yang, Donglin, Chen, Xin, Wei, Jialin, He, Yi, Zhang, Rongli, Zhai, Weihua, Ma, Qiaoling, Jiang, Erlie, Han, Mingzhe, Zhou, Jiaxi, Feng, Sizhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623918/
https://www.ncbi.nlm.nih.gov/pubmed/36316734
http://dx.doi.org/10.1186/s12935-022-02750-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623918/
https://www.ncbi.nlm.nih.gov/pubmed/36316734
http://dx.doi.org/10.1186/s12935-022-02750-4

Ejemplares similares